ALNY
AlnylamBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ALNY vs peer average
62/100
ALNY vs. peer average (B vs. C)
Grade spread
A 3 · B 2 · C 2 · D 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ARWR is the first available peer comparator.
Gene‑silencing therapeutics developer with pipeline focus overlapping on hepatic delivery; comparable platform-stage risks.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ALNY
Alnylam
ARWR
Arrowhead
Grade
B
A
Momentum
19
86
Value
58
57
Sentiment
95
63
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ARWR
ALNY / ARWR
Grade Position
In line
ALNY vs. peer average (B vs. C)
62/100
Momentum
19
ARWRValue
58
ALNYSentiment
95
ALNYRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ALNY
ARWR is the first peer returned for this comparison set.